SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001818382-22-000009
Filing Date
2022-03-29
Accepted
2022-03-29 07:04:11
Documents
15
Period of Report
2022-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K huma-20220329.htm   iXBRL 8-K 41800
2 EX-99.1 huma-20220329xexx991.htm EX-99.1 113436
7 imagea.jpg GRAPHIC 39911
  Complete submission text file 0001818382-22-000009.txt   409328

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT huma-20220329.xsd EX-101.SCH 2311
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT huma-20220329_def.xml EX-101.DEF 15952
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT huma-20220329_lab.xml EX-101.LAB 30825
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT huma-20220329_pre.xml EX-101.PRE 16624
9 EXTRACTED XBRL INSTANCE DOCUMENT huma-20220329_htm.xml XML 14690
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 22777343
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences